NovaBridge Biosciences (NBP) Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Assets data on file, last reported at $260.5 million in Q4 2025.

• Quarterly Assets rose 22.49% year-over-year to $260.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $260.5 million (up 22.49% YoY) and the FY2025 annual result came in at $260.5 million, up 22.49% from the prior year.
• Assets retreated to $260.5 million in Q4 2025 per NBP's latest filing, from $277.4 million in the prior quarter.
• Across five years, Assets topped out at $952.2 million in Q2 2021 and bottomed at $206.7 million in Q2 2025.
• The 5-year median for Assets is $277.4 million (2025), against an average of $434.3 million.
• The widest annual swing landed in 2021, when Assets soared 228.37%; it then sank 47.59% in 2024.
• Tracing NBP's Assets over 5 years: stood at $876.1 million in 2021, then sank by 34.62% to $572.8 million in 2022, then tumbled by 36.64% to $362.9 million in 2023, then plunged by 41.4% to $212.7 million in 2024, then rose by 22.49% to $260.5 million in 2025.
• Per Business Quant, the three latest NBP Assets figures stand at $260.5 million (Q4 2025), $277.4 million (Q3 2025), and $206.7 million (Q2 2025).

Peer Comparison